Andronesi OC, Kim GS, Gerstner E et al (2012) Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 4:116ra114. https://doi.org/10.1126/scitranslmed.3002693

Article  CAS  Google Scholar 

Arita H, Kinoshita M, Kagawa N et al (2012) (1)(1)C-methionine uptake and intraoperative 5-aminolevulinic acid-induced fluorescence as separate index markers of cell density in glioma: a stereotactic image-histological analysis. Cancer 118:1619–1627. https://doi.org/10.1002/cncr.26445

Article  CAS  PubMed  Google Scholar 

Brat DJ, Aldape K, Colman H et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.” Acta Neuropathol 136:805–810. https://doi.org/10.1007/s00401-018-1913-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujimoto K, Arita H, Satomi K et al (2021) TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol 142:323–338. https://doi.org/10.1007/s00401-021-02337-9

Article  CAS  PubMed  Google Scholar 

Hatakeyama T, Kawai N, Nishiyama Y et al (2008) 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging 35:2009–2017. https://doi.org/10.1007/s00259-008-0847-5

Article  CAS  PubMed  Google Scholar 

Ikeda S, Sakata A, Fushimi Y et al (2023) Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: the value of perfusion-weighted image, diffusion-weighted image, and (18)F-FDG-PET. Eur J Radiol 159:110658. https://doi.org/10.1016/j.ejrad.2022.110658

Article  PubMed  Google Scholar 

Izquierdo C, Barritault M, Poncet D et al (2019) Radiological characteristics and natural history of adult IDH-wildtype astrocytomas with TERT promoter mutations. Neurosurgery 85:E448–E456. https://doi.org/10.1093/neuros/nyy513

Article  PubMed  Google Scholar 

Kinoshita M, Arita H, Takahashi M et al (2020) Impact of inversion time for FLAIR acquisition on the T2-FLAIR mismatch detectability for IDH-mutant, Non-CODEL astrocytomas. Front Oncol 10:596448. https://doi.org/10.3389/fonc.2020.596448

Article  PubMed  Google Scholar 

Kurokawa R, Hagiwara A, Kurokawa M et al (2024) Diffusion histogram profiles predict molecular features of grade 4 in histologically lower-grade adult diffuse gliomas following WHO classification 2021. Eur Radiol 34:1367–1375. https://doi.org/10.1007/s00330-023-10071-x

Article  PubMed  Google Scholar 

Mesny E, Barritault M, Izquierdo C et al (2022) Gyriform infiltration as imaging biomarker for molecular glioblastomas. J Neurooncol 157:511–521. https://doi.org/10.1007/s11060-022-03995-9

Article  CAS  PubMed  Google Scholar 

Okita Y, Kinoshita M, Goto T et al (2010) (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage 49:2977–2982. https://doi.org/10.1016/j.neuroimage.2009.11.024

Article  PubMed  Google Scholar 

Organization WH (2021) Central nervous system tumours. International Agency for Research on Cancer, Lyon

Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res 23:6078–6085. https://doi.org/10.1158/1078-0432.CCR-17-0560

Article  CAS  PubMed  Google Scholar 

Stichel D, Ebrahimi A, Reuss D et al (2018) Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol 136:793–803. https://doi.org/10.1007/s00401-018-1905-0

Article  PubMed  Google Scholar 

Umehara T, Arita H, Yoshioka E et al (2019) Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts. Acta Neuropathol Commun 7:15. https://doi.org/10.1186/s40478-019-0749-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Bent MJ, Smits M, Kros JM et al (2017) Diffuse infiltrating oligodendroglioma and astrocytoma. J Clin Oncol 35:2394–2401. https://doi.org/10.1200/JCO.2017.72.6737

Article  PubMed  Google Scholar 

Wijnenga MMJ, French PJ, Dubbink HJ et al (2018) The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro Oncol 20:103–112. https://doi.org/10.1093/neuonc/nox176

Article  CAS  PubMed  Google Scholar 

Yamamoto S, Okita Y, Arita H et al (2023) Qualitative MR features to identify non-enhancing tumors within glioblastoma’s T2-FLAIR hyperintense lesions. J Neurooncol 165:251–259. https://doi.org/10.1007/s11060-023-04454-9

Article  PubMed  Google Scholar